AKT1 and ovarian carcinoma: Other research shows that tangeretin, a citrus flavonoid, reverses cisplatin resistance in ovarian cancer and enhances cisplatin sensitivity of ovarian cancer by inhibiting the PI3K/Akt signaling pathway [82].